Literature DB >> 2257225

Cisplatin and CCNU synergism in spheroid cell subpopulations.

R E Durand1.   

Abstract

The cytotoxicity of two antineoplastic drugs, cisplatin and CCNU, was evaluated in Chinese hamster V79 multicell spheroids using the drugs as single agents or combinations. Cells obtained from different depths within spheroids 550-750 microns in diameter showed different sensitivities to the two agents; the external cells of the spheroids were more sensitive than the internal cells to cisplatin, whereas the internal cells were most effectively killed by CCNU. Combining the two agents produced the expected 'complementary' activity, and in addition, synergism was observed between the drugs at exposure levels practical for clinical use. For the combination treatments, both the net pattern of cell killing through the spheroid and the degree of interaction between the agents (quantified using the combination index method) were a function of the dose ratio of the two drugs, and of overall treatment intensity. BCNU produced patterns of cell killing similar to CCNU, but showed little interaction with cisplatin. Our results suggest significant clinical potential in using CCNU with cisplatin, particularly since CCNU-cisplatin combinations were synergistic even in the cell subpopulations most resistant to each drug as a single agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257225      PMCID: PMC1971572          DOI: 10.1038/bjc.1990.415

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Distribution and activity of antineoplastic drugs in a tumor model.

Authors:  R E Durand
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

Review 2.  Contributions of nitrosoureas to cancer treatment.

Authors:  E P Mitchell; P S Schein
Journal:  Cancer Treat Rep       Date:  1986-01

3.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

4.  Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.

Authors:  G G Steel; M J Peckham
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-01       Impact factor: 7.038

5.  Development of tetraploidy in V79 spheroids.

Authors:  P L Olive; J C Leonard; R E Durand
Journal:  In Vitro       Date:  1982-08

6.  Radiation response of multicell spheroids--an in vitro tumour model.

Authors:  R M Sutherland; R E Durand
Journal:  Curr Top Radiat Res Q       Date:  1976-01

Review 7.  Cisplatin (cis-diamminedichloroplatinum II).

Authors:  A W Prestayko; J C D'Aoust; B F Issell; S T Crooke
Journal:  Cancer Treat Rev       Date:  1979-03       Impact factor: 12.111

8.  cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Authors:  F M Schabel; M W Trader; W R Laster; T H Corbett; D P Griswold
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

9.  Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains.

Authors:  R S Day; C H Ziolkowski; D A Scudiero; S A Meyer; A S Lubiniecki; A J Girardi; S M Galloway; G D Bynum
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

10.  Penetration of substances into tumor tissue--a methodological study on cellular spheroids.

Authors:  T Nederman; J Carlsson; M Malmqvist
Journal:  In Vitro       Date:  1981-04
View more
  4 in total

1.  Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.

Authors:  C Grau; J Overgaard
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

3.  The biological activity of cisplatin and dibromodulcitol in combination therapy.

Authors:  A Jeney; I Kovalszky; E Rásó; R E Durand; J Fürész; K Lapis
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

4.  Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.

Authors:  J Luo; I F Tannock
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.